Evidence map›Paper›PMID 41501553›Full record

ArticleNature chemistry2026

Homologative alkene difunctionalization.

Morgan Kim, So Yeon Ahn, Seongmin Kim, Junhwan Won, Dongwook Kim, Seung Youn Hong

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Morgan Kim *Department of Chemistry, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0007-8676-1394
So Yeon Ahn *Department of Chemistry, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0007-0034-251X
Seongmin Kim *Department of Chemistry, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0008-3822-7178
Junhwan WonDepartment of Chemistry, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0007-8660-7354
Dongwook KimCenter for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science, Daejeon, Republic of Korea.ORCID http://orcid.org/0000-0003-4432-371X
Seung Youn HongDepartment of Chemistry, Seoul National University, Seoul, Republic of Korea. syhong@snu.ac.kr.ORCID http://orcid.org/0000-0003-0113-5276

Funding

National Research Foundation of Korea (NRF) RS-2023-00214144National Research Foundation of Korea (NRF) RS-2023-00301976National Research Foundation of Korea (NRF) RS-2024-00403103National Research Foundation of Korea (NRF) RS-2024-00409659
6 · The paper itself

Abstract

Systematic evaluation of homologous series plays a pivotal role in synthetic and medicinal chemistry. Despite their structural resemblance, the preparation of homologues often requires individual synthetic planning tailored to distinct precursors and reactions. Here we introduce a strategy that integrates single-carbon insertion into established methods, specifically redirecting alkene vicinal difunctionalization towards direct routes for 1,3-difunctionalized products. This transformation is enabled by a designer methylene dication reagent, iodomethylthianthrenium salt, which facilitates the photocatalytic conversion of alkenes into linchpin 1,3-dielectrophilic intermediates, allowing seamless incorporation of nucleophiles at distal positions. Mechanistic studies suggest that the reaction proceeds via an α-thianthrenium methyl radical with unusual ambiphilic reactivity governed by multiple stereoelectronic effects. This approach shows high compatibility in pharmaceutical and late-stage settings, providing broad access to diverse 1,3-difunctionalized products, including azetidines, 1,3-diazides and 1,3-dihalides. This work establishes 'homologative alkene difunctionalization' as a powerful platform for repurposing ubiquitous alkenes as meritorious synthetic intermediates to unveil heretofore unknown 1,3-substitution patterns.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.